Måndag 19 Oktober | 10:03:45 Europe / Stockholm
Svenska | English
Kursutveckling under dagen för detta pressmeddelande (EUR).
Likviditet under dagen för detta pressmeddelande
Est. tid*
2026-10-23 09:30 Kvartalsrapport 2026-Q3
2026-08-21 - Kvartalsrapport 2026-Q2
2026-05-05 - X-dag ordinarie utdelning MODU 0.00 EUR
2026-05-04 - Årsstämma
2026-04-24 - Kvartalsrapport 2026-Q1
2026-02-20 - Bokslutskommuniké 2025
2025-10-24 - Kvartalsrapport 2025-Q3
2025-08-22 - Kvartalsrapport 2025-Q2
2025-05-05 - X-dag ordinarie utdelning MODU 0.00 EUR
2025-05-02 - Årsstämma
2025-04-25 - Kvartalsrapport 2025-Q1
2025-02-21 - Bokslutskommuniké 2024
2024-10-18 - Kvartalsrapport 2024-Q3
2024-08-16 - Kvartalsrapport 2024-Q2
2024-05-06 - X-dag ordinarie utdelning MODU 0.00 EUR
2024-04-26 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-10-20 - 15-10 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2023-05-02 - Årsstämma
2023-04-28 - 15-10 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-08-19 - Kvartalsrapport 2022-Q2
2022-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2022-05-02 - Årsstämma
LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Modulight är verksamt inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består huvudsakligen av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom Europa.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Modulight to publish its interim report for January–September 2026 on October 23, 2026

2026-10-16 10:20:00

Modulight Corporation | Press Release | October 16, 2026 at 11:20:00 EEST

Modulight Corporation will publish its interim report for January–September 2026 on Friday, October 23, 2026, at approximately 10:30 a.m. EEST.

Modulight's CEO Seppo Orsila will present the result in an English-language webcast on October 26, 2026, at 11:00 a.m. EET. Registration and access to the webcast are available through the following link: https://modulight.zoom.us/webinar/register/WN_-b50yFg3Qumbt2Xn3NlmDg

Questions are to be submitted in writing in the webcast portal. CFO Anca Guina will also be present to answer questions. Presentation materials will be available before the start of the event on the company’s website at modulight.com/reports-presentations/.

Contacts

CEO Seppo Orsila m. +358 40 830 4671
CFO Anca Guina m. +358 40 830 4674
IR Ulla Haapanen m. +358 40 830 4676
Email: ir@modulight.com

Modulight in brief

Modulight Corporation is a life science company that designs and manufactures laser devices for the treatment of cancer and eye diseases. The company also manufactures products for other high value-add applications including flow cytometry, microscopy, semiconductor, quantum, and defense. The company’s products include medical devices, subsystems, software, cloud services, and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.

Follow Modulight: modulight.com | X | LinkedIn | Facebook | YouTube | Instagram | #KillCancer

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Företag
Pressmeddelanden